Find out what Novartis' pipeline strategy since it spun off its biosimilars and generics business Sandoz, and engage in ...

Discover Prague's biotech hub, now viewed as the primary ‘entry gateway’ into the wider Central and Eastern European ...

Despite decades of progress in oncology, the majority of cancer drugs that enter clinical trials never reach the market and the patients who need them most. Late-stage failure remains one of the most ...